Clinical trial
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
NCT00022074 · Gary Morrow, Other · Completed
Key facts
| NCT number | NCT00022074 |
|---|---|
| Title | Gabapentin For the Control of Hot Flashes in Women With Breast Cancer |
| Official title | Control of Vasomotor Symptoms in Women Treated for Breast Cancer |
| Lead sponsor | Gary Morrow, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Anxiety Disorder, Breast Cancer, Depression, Hot Flashes |
| Intervention type | Drug, Procedure |
| Interventions | gabapentin, quality-of-life assessment |
| Start date | Jul 1, 2001 |
| Primary completion | Jun 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Oct 15, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: